Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1037 gün önce
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

Etiketler: HOTH
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 781 gün önce
CAC 40 Modestly Lower In Cautious Trade After Inflation Data

CAC 40 Modestly Lower In Cautious Trade After Inflation Data

The French market is modestly lower on Friday with investors reacting to regional inflation data, and recent earnings updates and central bank policy decisions, in addition to weighing the developments on trade and geopolitical fronts.
RTTNews | 24 dakika önce
UK Nationwide House Price Growth Softens

UK Nationwide House Price Growth Softens

UK house prices increased at a slower pace in October as buyers were cautious ahead of the budget, data from the Nationwide Building Society showed Friday. House price posted a monthly growth of 0.3 percent in October, slower than the 0.5 percent rise seen a month ago. Nonetheless, the figure was better than the forecast of nil growth.
RTTNews | 29 dakika önce
DAX Drops To 2-month Low

DAX Drops To 2-month Low

German stocks are down in negative territory on Friday and the benchmark DAX is near two-month lows, as investors, assessing the recent interest rate decisions of the major central banks, and the developments on the trade front, remain cautious and mostly making cautious moves.
RTTNews | 1s 13 dakika önce
Sensex, Nifty End Lower On Mixed Global Cues

Sensex, Nifty End Lower On Mixed Global Cues

Indian shares ended lower on Friday as renewed foreign investor selling overshadowed upbeat corporate earnings and easing global trade tensions.
RTTNews | 1s 23 dakika önce
European Shares Subdued Before Key Inflation Reading

European Shares Subdued Before Key Inflation Reading

European stocks drifted lower on Friday, and the euro consolidated losses ahead of key Eurozone inflation data due later in the day. Earlier in the day, data showed that French consumer price inflation slowed further below the European Central Bank's target in October despite an unexpectedly strong upswing in the economy.
RTTNews | 2s 40 dakika önce